Fatih Sultan Mehmet Eğitim ve Araştırma Hastanesi
Istanbul, Ataşehir, 34752, Turkey (Türkiye)
NCT Number: NCT07102732
The goal of this validation and reliability study is to translate the modified version of the New Mobility Score (NMS) into Turkish (NMS-TR), culturally adapt it, and examine its psychometric properties in elderly individuals (aged 65 years and older) with hip fractures.
The main questions it aims to answer are:
1. Is the New Mobility Score a valid and reliable measurement tool for assessing mobility in Turkish individuals with hip fractures? 2. Is the New Mobility Score not a valid and reliable measurement tool in this population?
There is no comparison group in this study.
Participants will:
Provide demographic and clinical information. Undergo cognitive assessment using the Mini-Mental State Examination (MMSE). Be evaluated for comorbidity burden using the Charlson Comorbidity Index (CCI). Have their ambulatory function assessed with the Cumulative Ambulation Score (CAS).
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Istanbul, Ataşehir, 34752, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From enrollment, all measurements were repeated within 2 to 7 days following the initial assessment to evaluate test-retest reliability.
The NMS requires a self-report on the ability to complete walking tasks in different settings, including indoor walking (e.g., within a house), outdoor walking, and walking during shopping. Each item is scored on a scale from 0 to 3 based on the individual's self-reported ability: a score of 0 indicates the individual was unable to complete the task, a score of 1 indicates the individual required assistance from another person to complete the task, a score of 2 indicates the individual completed the task with the aid of a walking aid, and a score of 3 indicates the individual completed the task independently without any walking assistance.
Time frame: From enrollment, all measurements were repeated within 2 to 7 days following the initial assessment to evaluate test-retest reliability.
The Cumulative Ambulation Score assesses four distinct activities (getting out of bed, sitting, and walking) using a three-point ordinal scale ranging from 0 to 2. A score of 0 indicates that the individual is unable to perform the activity despite human assistance and verbal cues; a score of 1 signifies that the activity can be performed with human assistance and/or verbal prompting from one or more individuals; and a score of 2 denotes the ability to perform the activity safely without human assistance or verbal prompting, although the use of a walking aid is permitted. The total score ranges from 0 to 6.
Time frame: From enrollment, all measurements were repeated within 2 to 7 days following the initial assessment to evaluate test-retest reliability.
The total score of this test ranges from 0 to 30, with lower scores indicating more pronounced cognitive impairment. In the literature, a cut-off score of 24 is commonly accepted, with scores of 24 or below suggesting a risk of cognitive impairment.
Time frame: From enrollment, all measurements were repeated within 2 to 7 days following the initial assessment to evaluate test-retest reliability.
The Charlson Comorbidity Index (CCI) is a common tool used to estimate patients' long-term mortality risk. This index plays an important role in assessing health outcomes by measuring the burden of comorbidities that patients have.
Istanbul Rumeli University
Other
VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE MODIFIED NEW MOBILITY SCORE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01714336
Femoral Fractures, Fractures, Bone
Rochester, Minnesota, United States
View Trial DetailsNCT00046254
Bone Diseases, Bone Diseases, Metabolic
Birmingham, Alabama, United States
View Trial DetailsNCT06961253
Femoral Fractures, Fractures, Bone
Amsterdam, Netherlands
View Trial DetailsNCT07639762
Agnosia, Femoral Fractures
Istanbul, Sancaktepe, Turkey (Türkiye)
View Trial Details